PET/CT in Lymphomas: Current clinical applications and future directions.
PET/CT imaging remains the standard for lymphoma diagnosis and monitoring, with emerging AI and liquid biopsy integration pointing toward earlier detection.
PET/CT is the standard of care for staging, response assessment, and surveillance in lymphoma; emerging applications include minimal residual disease detection, liquid biopsy integration, and AI-based radiomics for personalised treatment adaptation. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- narrative_review
- Category
- hematologic_malignancies
- Maturity
- Validated
- Journal
- Hellenic Journal of Nuclear Medicine
Why it surfaced
Timely state-of-the-art review of PET/CT in lymphoma; relevant to hematologic malignancy imaging standard of care and AI-diagnostics pipeline intersection.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.